Shopping Cart
Remove All
Your shopping cart is currently empty
Narnatumab (IMC-RON8) is a humanized antibody targeting the macrophage-stimulating receptor (RON) with antitumor activity, used in advanced malignant solid tumors research.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $447 | - | In Stock | |
| 5 mg | $1,400 | - | In Stock | |
| 10 mg | $2,240 | - | In Stock | |
| 25 mg | $4,210 | - | In Stock |
| Description | Narnatumab (IMC-RON8) is a humanized antibody targeting the macrophage-stimulating receptor (RON) with antitumor activity, used in advanced malignant solid tumors research. |
| Targets&IC50 | RON:32 pM (Kd) |
| In vitro | Narnatumab is a fully humanized monoclonal antibody that binds to RON with high affinity and subsequently prevents RON from binding to HGFL. [1] |
| Synonyms | LY3012219, LY 3012219, IMC-RON-8, IMC-RON8, IMCRON8, Anti-MSPR/RON/CD136 Reference Antibody |
| Cas No. | 1188275-92-4 |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.